HER2-low and HER2-ultralow breast cancer in the antibody-drug conjugate era: diagnostic challenges and reporting workflow

Diagnostic Pathology · Published 2026-08-01 · DOI 10.1186/s13000-026-01822-7

Free full text

Authors (6)

Kuan Liang, Ziang Jia, Haiwen Lu, Ziling Yan, Haihui Huang, Xia Liu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Liang, K., Jia, Z., Lu, H., et al. (2026). HER2-low and HER2-ultralow breast cancer in the antibody-drug conjugate era: diagnostic challenges and reporting workflow. Diagnostic Pathology. https://doi.org/10.1186/s13000-026-01822-7

Related articles